← All organizations

Poxel SA

For profitWebsite ↗

Also known as: Poxel SA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Dec 31, 2022

Timeline

2000s

Jun 1, 2009
Poxel SA— Founded

Drugs by trial phase (6 distinct, 14 trials)

Phase 2 (3 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (16)

NCT05200104Lead sponsorPhase 2Dec 31, 2022
NCT05146284Lead sponsorPhase 2Mar 31, 2022
NCT05441904Lead sponsorPhase 1Mar 8, 2021
NCT04321343Lead sponsorPhase 2Jun 30, 2020
NCT03950882Lead sponsorPhase 1May 27, 2019
NCT03763877Lead sponsorPhase 2Mar 29, 2019
NCT03886103Lead sponsorPhase 1Feb 6, 2019
NCT03802786Lead sponsorPhase 1Nov 6, 2018
NCT03802786Study directorPhase 1Nov 6, 2018
NCT03646331Lead sponsorPhase 1Aug 30, 2018
NCT03618316Lead sponsorPhase 1Jun 19, 2018
NCT03395470Lead sponsorPhase 1Aug 21, 2017
NCT02924337Lead sponsorPhase 1Sep 1, 2016
NCT02924337Study directorPhase 1Sep 1, 2016
NCT02373150Lead sponsorPhase 1Feb 1, 2015

Details

Founded: Lyon, FR Jun 1, 2009
Last known activity: Dec 31, 2022